← Open Payments lookup

MATTHEW STAWARZ: Open Payments

NPI 1376231548 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,329 in 71 payments from 11 companies in 2025. Trend: 2023 $444 · 2024 $1,640 · 2025 $1,329

Food & beverage: $1,329
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation17$284
AstraZeneca Pharmaceuticals LP11$251
E.R. Squibb & Sons, L.L.C.16$148
Novo Nordisk Inc6$145
Bayer Healthcare Pharmaceuticals Inc.6$121
Abbott Laboratories1$114
Merck Sharp & Dohme LLC5$93
BridgeBio Pharma, Inc.2$56
Amgen Inc.3$52
Boehringer Ingelheim Pharmaceuticals, Inc.2$37

Products named: LEQVIO, CAMZYOS, Wegovy, Kerendia, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, FARXIGA, WAINUA, VERQUVO.

Industry payments across VA — which companies pay providers there.